Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
-
Source:
A Phase IIa/IIb, Randomised, Double Blind, Placebo-controlled, Parallel-group Dose-finding Study to Examine the Efficacy and Safety of BI 1839100 Administered Orally Over a 12-week Treatment Period in
تفاصيل العنوان
-
Source:
An Open-label Extension Study of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis
تفاصيل العنوان
-
Source:
An Open-label Extension Trial of the Long-term Safety and Efficacy of BI 1015550 Taken Orally in Patients With Idiopathic Pulmonary
تفاصيل العنوان
-
Source:
Characterization of Apolipoprotein A-I Pathways in Idiopathic Pulmonary Fibrosis
تفاصيل العنوان
-
Authors :
Tanzira Zaman, Principal Investigator
-
Source:
Feasibility of a Decentralized Double-Blind Randomized Controlled Trial of Zinc and Nicotinamide Riboside for the Treatment of Idiopathic Pulmonary
تفاصيل العنوان
-
Source:
Ongoing Monitoring of Vital Signs in Patients With Idiopathic Pulmonary Fibrosis Before and After Acute Exacerbation. (REACT)
تفاصيل العنوان
-
Source:
A Phase 2, Randomized, Double-Blind, Placebo Controlled, Parallel Group Study (TRANSFORM) to Evaluate the Efficacy and Safety of GSK3915393 in Participants With Idiopathic
تفاصيل العنوان
-
Source:
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic
تفاصيل العنوان
-
Source:
A Double Blind, Randomized, Placebo-controlled Trial Evaluating the Efficacy and Safety of BI 1015550 Over at Least 52 Weeks in Patients With Idiopathic Pulmonary
تفاصيل العنوان
-
Source:
Analysis of Specimens From Individuals With Pulmonary FibrosisHan CG, O'Brien KJ, Coon LM, Majerus JA, Huryn LA, Haroutunian SG,
تفاصيل العنوان